PEPLIN PHARMACEUTICALS FOR LIFE



Trademark Coverage

No Class Specified

Research and development, in relation to medical, biological and/or chemical diagnostic preparations, namely the identification evaluation and development of pharmaceuticals, pharmaceuticals for the treatment, prevention and diagnosis of diabetes, dermatological, respiratory and/or inflammatory conditions, namely, acne, angina, arthritis, aspiration pneumonia, emphysema, gastroenteritis, intestinal flu, necrotizing enterocolitis, pelvic inflammatory disease, pharyngitis, PID, pleurisy, raw throat, redness, rubor, sore throat, stomach flu and urinary tract infections, chronic inflammatory demyelinating polyneuropathy, chronic inflammatory demyelinating polyradiculoneuropathy; Research and development in relation to cancers including tumors, sarcomas, carcinomas and melanomas including tumors of the colon, breast, neck, throat, bladder, brain, liver, pancreas, adrenal glands, lymph, testicles, uterus, ovaries, lung as well solid and blood borne tumors such as ABL1 protooncogene, AIDS related cancers, acoustic neuroma, acute lymphocytic leukemia, acute myeloid leukemia, adenocystic carcinoma, adrenocortical cancer, agnogenic myeloid metaplasia, alopecia, alveolar soft-part sarcoma, anal cancer, angiosarcoma, aplastic anemia, astrocytoma, ataxia-telangiectasia, basal cell carcinoma, bladder cancer, bone cancers, bowel cancer, brain stem glioma, brain and CNS tumors, breast cancer, CNS tumors, carcinoid tumors, cervical cancer, childhood brain tumors, childhood cancer, childhood leukemia, childhood soft tissue sarcoma, chondrosarcoma, choriocarcinoma, chronic lymphocytic leukemia, chronic myeloid leukemia, colorectal cancers, cutaneous T-cell lymphoma, dermatofibrosarcoma-protuberans, desmoplastic-small-round-cell-tumor, ductal carcinoma, endocrine cancers, endometrial cancer, ependymoma, esophageal cancer, Ewing's sarcoma, extra-hepatic bile duct cancer, eye cancer, fallopian tube cancer, fanconi anemia, fibrosarcoma, gall bladder cancer, gastric cancer, gastrointestinal cancers, gastrointestinal-carcinoid-tumor, genitourinary cancers, germ cell tumors, gestational-trophoblastic-disease, glioma, gynecological cancers, hematological malignancies, hairy cell leukemia, head and neck cancer, hepatocellular cancer, hereditary breast cancer, histiocytosis, Hodgkin's disease, human papillomavirus, hydatidiform mole, hypercalcemia, hypopharynx cancer, intraocular melanoma, islet cell cancer, Kaposi's sarcoma, kidney cancer, Langerhan's-cell-histiocytosis, laryngeal cancer, leiomyosarcoma, leukemia, Li-Fraumeni syndrome, lip cancer, liposarcoma, liver cancer, lung cancer, lymphedema, lymphoma, Hodgkin's lymphoma, non-Hodgkin's lymphoma, male breast cancer, malignant-rhabdoid-tumor-of-kidney, medulloblastoma, melanoma, Merkel cell cancer, mesothelioma, metastatic cancer, mouth cancer, multiple endocrine neoplasia, mycosis fungoides, myelodysplastic syndromes, myeloma, myeloproliferative disorders, nasal cancer, nasopharyngeal cancer, nephroblastoma, neuroblastoma, neurofibromatosis, Nijmegen breakage syndrome, non-melanoma skin cancer, non-small-cell-lung-cancer, ocular cancers, oesophageal cancer, oral cavity cancer, oropharynx cancer, osteosarcoma, ostomy ovarian cancer, pancreas cancer, paranasal cancer, parathyroid cancer, parotid gland cancer, penile cancer, peripheral-neuroectodermal-tumors, pituitary cancer, polycythemia vera, prostate cancer, rare-cancers-and-associated-disorders, renal cell carcinoma, retinoblastoma, rhabdomyosarcoma, Rothmund-Thomson syndrome, salivary gland cancer, schwannoma, Sezary syndrome, skin cancer, small cell lung cancer, small intestine cancer, soft tissue sarcoma, spinal cord tumors, squamous cell carcinoma, stomach cancer, synovial sarcoma, testicular cancer, thymus cancer, thyroid cancer, transitional-cell-cancer of the bladder, transitional-cell-cancer of the renal, pelvis, ureter, trophoblastic cancer, urethral cancer, urinary system cancer, uroplakins, uterine sarcoma, uterus cancer, vaginal cancer, vulva cancer, Waldenstrom's-macroglobulinemia and Wilms' tumor

Owners

PEPLIN LIMITED

Business in NEWSTEAD, QUEENSLAND, AU

Owns 1 trademark

Peplin Biotech Ltd

Business in Newstead, Queensland, AU

Owns 1 trademark

Timeline
  • Dec 06
    2013
    Cancelled SEC 8 (6 Yr)
  • Sep 05
    2013
    TEAS Change Of Correspondence Received
  • Aug 01
    2007
    Amendment Under Section 7 Issued
  • Jul 12
    2007
    Assigned To Paralegal
  • Jun 07
    2007
    SEC 7 Request Filed
  • Jun 07
    2007
    Paper Received
  • May 01
    2007
    Registered Principal Register
  • Feb 13
    2007
    Published For Opposition
  • Jan 24
    2007
    Notice Of Publication
  • Dec 15
    2006
    Law Office Publication Review Completed
  • Dec 14
    2006
    Assigned To LIE
  • Nov 29
    2006
    Approved For PUB Principal Register
  • Nov 08
    2006
    TEAS/Email Correspondence Entered
  • Nov 02
    2006
    Correspondence Received In Law Office
  • Nov 02
    2006
    TEAS Response To Office Action Received
  • May 05
    2006
    Non Final Action Mailed
  • May 05
    2006
    Non Final Action Written
  • Apr 06
    2006
    TEAS/Email Correspondence Entered
  • Mar 31
    2006
    Correspondence Received In Law Office
  • Apr 05
    2006
    Automatic Update Of Assignment Of Ownership
  • Mar 31
    2006
    TEAS Response To Office Action Received
  • Feb 10
    2006
    Amendment From Applicant Entered
  • Jan 27
    2006
    Correspondence Received In Law Office
  • Jan 27
    2006
    TEAS Response To Office Action Received
  • Nov 23
    2005
    Letter Of Suspension Mailed
  • Nov 23
    2005
    Suspension Letter Written
  • Nov 01
    2005
    TEAS/Email Correspondence Entered
  • Oct 26
    2005
    Correspondence Received In Law Office
  • Oct 26
    2005
    TEAS Response To Office Action Received
  • Apr 27
    2005
    Non Final Action Mailed
  • Apr 27
    2005
    Non Final Action Written
  • Apr 17
    2005
    Assigned To Examiner
  • Sep 22
    2004
    New Application Entered In TRAM